Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes.

Published in:

Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15954

By:

• Simpson, Eric;
• Armstrong, April;
• Boguniewicz, Mark;
• Chiesa Fuxench, Zelma C.;
• Feely, Meghan;
• Pierce, Evangeline;
• Sun, Luna;
• Chen, Yun‐Fei;
• Angle, Robinette;
• Silverberg, Jonathan I.

Publication type:

Article